| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -16 @ USD 151.37 | USD -2,422 | The ETF sold 16 shares of DVA on 2025-03-26. The shares were previously bought for an average price of USD 156.826. The DaVita HealthCare Partners Inc shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 87 The average price that the ETF previously sold DVA share for is USD 155.494 which is higher than the selling price of USD 151.37 on 2025-03-26. |
| CRL - Creightons Plc | SELL | -19 @ USD 158.25 | USD -3,007 | The ETF sold 19 shares of CRL on 2025-03-26. The shares were previously bought for an average price of USD 173.565. The Creightons Plc shares were sold for -8.8% lower than average price of previous purchases. This resulted in an overall loss of USD 291 The average price that the ETF previously sold CRL share for is USD 200.311 which is higher than the selling price of USD 158.25 on 2025-03-26. |
| HSIC - Henry Schein Inc | SELL | -46 @ USD 69.75 | USD -3,209 | The ETF sold 46 shares of HSIC on 2025-03-26. The shares were previously bought for an average price of USD 74.1188. The Henry Schein Inc shares were sold for -5.9% lower than average price of previous purchases. This resulted in an overall loss of USD 201 The average price that the ETF previously sold HSIC share for is USD 72.431 which is higher than the selling price of USD 69.75 on 2025-03-26. |
| TECH - Bio-Techne Corp | SELL | -55 @ USD 59.38 | USD -3,266 | The ETF sold 55 shares of TECH on 2025-03-26. The shares were previously bought for an average price of USD 68.3676. The Bio-Techne Corp shares were sold for -13.1% lower than average price of previous purchases. This resulted in an overall loss of USD 494 The average price that the ETF previously sold TECH share for is USD 73.353 which is higher than the selling price of USD 59.38 on 2025-03-26. |
| INCY - Incyte Corporation | SELL | -57 @ USD 61.26 | USD -3,492 | The ETF sold 57 shares of INCY on 2025-03-26. The shares were previously bought for an average price of USD 70.7214. The Incyte Corporation shares were sold for -13.4% lower than average price of previous purchases. This resulted in an overall loss of USD 539 The average price that the ETF previously sold INCY share for is USD 75.6746 which is higher than the selling price of USD 61.26 on 2025-03-26. |
| SOLV - Solventum Corp. | SELL | -48 @ USD 74.24 | USD -3,564 | The ETF sold 48 shares of SOLV on 2025-03-26. The shares were previously bought for an average price of USD 74.5848. The Solventum Corp. shares were sold for -0.5% lower than average price of previous purchases. This resulted in an overall loss of USD 17 The average price that the ETF previously sold SOLV share for is USD 71.4367 so the ETF has sold 48 shares on 2025-03-26 at a higher price than the previous selling average. |
| MRNA - Moderna Inc | SELL | -121 @ USD 31.48 | USD -3,809 | The ETF sold 121 shares of MRNA on 2025-03-26. The shares were previously bought for an average price of USD 37.6579. The Moderna Inc shares were sold for -16.4% lower than average price of previous purchases. This resulted in an overall loss of USD 748 The average price that the ETF previously sold MRNA share for is USD 44.0757 which is higher than the selling price of USD 31.48 on 2025-03-26. |
| VTRS - Viatris Inc | SELL | -437 @ USD 8.96 | USD -3,916 | The ETF sold 437 shares of VTRS on 2025-03-26. The shares were previously bought for an average price of USD 10.7769. The Viatris Inc shares were sold for -16.9% lower than average price of previous purchases. This resulted in an overall loss of USD 794 The average price that the ETF previously sold VTRS share for is USD 12.763 which is higher than the selling price of USD 8.96 on 2025-03-26. |
| ALGN - Align Technology Inc | SELL | -24 @ USD 166.46 | USD -3,995 | The ETF sold 24 shares of ALGN on 2025-03-26. The shares were previously bought for an average price of USD 193.979. The Align Technology Inc shares were sold for -14.2% lower than average price of previous purchases. This resulted in an overall loss of USD 660 The average price that the ETF previously sold ALGN share for is USD 226.028 which is higher than the selling price of USD 166.46 on 2025-03-26. |
| UHS - Universal Health Services Inc | SELL | -22 @ USD 184.46 | USD -4,058 | The ETF sold 22 shares of UHS on 2025-03-26. The shares were previously bought for an average price of USD 190.514. The Universal Health Services Inc shares were sold for -3.2% lower than average price of previous purchases. This resulted in an overall loss of USD 133 The average price that the ETF previously sold UHS share for is USD 197.97 which is higher than the selling price of USD 184.46 on 2025-03-26. |
| RVTY - Revvity Inc. | SELL | -40 @ USD 107.36 | USD -4,294 | The ETF sold 40 shares of RVTY on 2025-03-26. The shares were previously bought for an average price of USD 114.806. The Revvity Inc. shares were sold for -6.5% lower than average price of previous purchases. This resulted in an overall loss of USD 298 The average price that the ETF previously sold RVTY share for is USD 117.652 which is higher than the selling price of USD 107.36 on 2025-03-26. |
| HOLX - Hologic Inc | SELL | -79 @ USD 61.48 | USD -4,857 | The ETF sold 79 shares of HOLX on 2025-03-26. The shares were previously bought for an average price of USD 68.6193. The Hologic Inc shares were sold for -10.4% lower than average price of previous purchases. This resulted in an overall loss of USD 564 The average price that the ETF previously sold HOLX share for is USD 74.0536 which is higher than the selling price of USD 61.48 on 2025-03-26. |
| WST - West Pharmaceutical Services Inc | SELL | -24 @ USD 224.91 | USD -5,398 | The ETF sold 24 shares of WST on 2025-03-26. The shares were previously bought for an average price of USD 270.648. The West Pharmaceutical Services Inc shares were sold for -16.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,098 The average price that the ETF previously sold WST share for is USD 312.497 which is higher than the selling price of USD 224.91 on 2025-03-26. |
| MOH - MOH | SELL | -18 @ USD 323.44 | USD -5,822 | The ETF sold 18 shares of MOH on 2025-03-26. The shares were previously bought for an average price of USD 304.806. The MOH shares were sold for 6.1% higher than average price of previous purchases. This sale made a profit of USD 335 The average price that the ETF previously sold MOH share for is USD 311.243 so the ETF has sold 18 shares on 2025-03-26 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -18 @ USD 323.44 | USD -5,822 | The ETF sold 18 shares of MOH on 2025-03-26. The shares were previously bought for an average price of USD 304.806. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 6.1% higher than average price of previous purchases. This sale made a profit of USD 335 The average price that the ETF previously sold MOH share for is USD 311.243 so the ETF has sold 18 shares on 2025-03-26 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -70 @ USD 83.86 | USD -5,870 | The ETF sold 70 shares of COO on 2025-03-26. The shares were previously bought for an average price of USD 90.8169. The The Cooper Companies, Inc. Common Stock shares were sold for -7.7% lower than average price of previous purchases. This resulted in an overall loss of USD 487 The average price that the ETF previously sold COO share for is USD 100.359 which is higher than the selling price of USD 83.86 on 2025-03-26. |
| BAX - Baxter International Inc | SELL | -180 @ USD 33.36 | USD -6,005 | The ETF sold 180 shares of BAX on 2025-03-26. The shares were previously bought for an average price of USD 33.4532. The Baxter International Inc shares were sold for -0.3% lower than average price of previous purchases. This resulted in an overall loss of USD 17 The average price that the ETF previously sold BAX share for is USD 33.5934 which is higher than the selling price of USD 33.36 on 2025-03-26. |
| PODD - Insulet Corporation | SELL | -23 @ USD 264.88 | USD -6,092 | The ETF sold 23 shares of PODD on 2025-03-26. The shares were previously bought for an average price of USD 270.465. The Insulet Corporation shares were sold for -2.1% lower than average price of previous purchases. This resulted in an overall loss of USD 128 The average price that the ETF previously sold PODD share for is USD 262.451 so the ETF has sold 23 shares on 2025-03-26 at a higher price than the previous selling average. |
| DGX - Quest Diagnostics Incorporated | SELL | -37 @ USD 166.62 | USD -6,165 | The ETF sold 37 shares of DGX on 2025-03-26. The shares were previously bought for an average price of USD 165.33. The Quest Diagnostics Incorporated shares were sold for 0.8% higher than average price of previous purchases. This sale made a profit of USD 48 The average price that the ETF previously sold DGX share for is USD 160.417 so the ETF has sold 37 shares on 2025-03-26 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -27 @ USD 233.34 | USD -6,300 | The ETF sold 27 shares of LH on 2025-03-26. The shares were previously bought for an average price of USD 242.946. The Laboratory Corporation of America Holdings shares were sold for -4.0% lower than average price of previous purchases. This resulted in an overall loss of USD 259 The average price that the ETF previously sold LH share for is USD 238.896 which is higher than the selling price of USD 233.34 on 2025-03-26. |
| BIIB - Biogen Inc | SELL | -49 @ USD 142.43 | USD -6,979 | The ETF sold 49 shares of BIIB on 2025-03-26. The shares were previously bought for an average price of USD 150.162. The Biogen Inc shares were sold for -5.1% lower than average price of previous purchases. This resulted in an overall loss of USD 379 The average price that the ETF previously sold BIIB share for is USD 163.648 which is higher than the selling price of USD 142.43 on 2025-03-26. |
| WAT - Waters Corporation | SELL | -20 @ USD 367.79 | USD -7,356 | The ETF sold 20 shares of WAT on 2025-03-26. The shares were previously bought for an average price of USD 375.768. The Waters Corporation shares were sold for -2.1% lower than average price of previous purchases. This resulted in an overall loss of USD 160 The average price that the ETF previously sold WAT share for is USD 378.085 which is higher than the selling price of USD 367.79 on 2025-03-26. |
| WAT - MULETFWATIMETFP | SELL | -20 @ USD 367.79 | USD -7,356 | The ETF sold 20 shares of WAT on 2025-03-26. The shares were previously bought for an average price of USD 375.768. The MULETFWATIMETFP shares were sold for -2.1% lower than average price of previous purchases. This resulted in an overall loss of USD 160 The average price that the ETF previously sold WAT share for is USD 378.085 which is higher than the selling price of USD 367.79 on 2025-03-26. |
| STE - STERIS plc | SELL | -33 @ USD 223.06 | USD -7,361 | The ETF sold 33 shares of STE on 2025-03-26. The shares were previously bought for an average price of USD 221.214. The STERIS plc shares were sold for 0.8% higher than average price of previous purchases. This sale made a profit of USD 61 The average price that the ETF previously sold STE share for is USD 217.662 so the ETF has sold 33 shares on 2025-03-26 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -70 @ USD 110.64 | USD -7,745 | The ETF sold 70 shares of ZBH on 2025-03-26. The shares were previously bought for an average price of USD 107.38. The Zimmer Biomet Holdings Inc shares were sold for 3.0% higher than average price of previous purchases. This sale made a profit of USD 228 The average price that the ETF previously sold ZBH share for is USD 109.05 so the ETF has sold 70 shares on 2025-03-26 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -8 @ USD 1191.03 | USD -9,528 | The ETF sold 8 shares of MTD on 2025-03-26. The shares were previously bought for an average price of USD 1272.28. The Mettler-Toledo International Inc shares were sold for -6.4% lower than average price of previous purchases. This resulted in an overall loss of USD 650 The average price that the ETF previously sold MTD share for is USD 1266.47 which is higher than the selling price of USD 1191.03 on 2025-03-26. |
| MTD - AMUNDI EUR GOV 710 | SELL | -8 @ USD 1191.03 | USD -9,528 | The ETF sold 8 shares of MTD on 2025-03-26. The shares were previously bought for an average price of USD 1272.28. The AMUNDI EUR GOV 710 shares were sold for -6.4% lower than average price of previous purchases. This resulted in an overall loss of USD 650 The average price that the ETF previously sold MTD share for is USD 1266.47 which is higher than the selling price of USD 1191.03 on 2025-03-26. |
| DXCM - DexCom Inc | SELL | -139 @ USD 72.13 | USD -10,026 | The ETF sold 139 shares of DXCM on 2025-03-26. The shares were previously bought for an average price of USD 79.8882. The DexCom Inc shares were sold for -9.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,078 The average price that the ETF previously sold DXCM share for is USD 74.8662 which is higher than the selling price of USD 72.13 on 2025-03-26. |
| CNC - Concurrent Technologies Plc | SELL | -172 @ USD 60.54 | USD -10,413 | The ETF sold 172 shares of CNC on 2025-03-26. The shares were previously bought for an average price of USD 60.1461. The Concurrent Technologies Plc shares were sold for 0.7% higher than average price of previous purchases. This sale made a profit of USD 68 The average price that the ETF previously sold CNC share for is USD 59.6634 so the ETF has sold 172 shares on 2025-03-26 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -58 @ USD 180.02 | USD -10,441 | The ETF sold 58 shares of IQV on 2025-03-26. The shares were previously bought for an average price of USD 200.181. The IQVIA Holdings Inc shares were sold for -10.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,169 The average price that the ETF previously sold IQV share for is USD 203.823 which is higher than the selling price of USD 180.02 on 2025-03-26. |
| HUM - Hummingbird Resources PLC | SELL | -41 @ USD 270.48 | USD -11,090 | The ETF sold 41 shares of HUM on 2025-03-26. The shares were previously bought for an average price of USD 273.181. The Hummingbird Resources PLC shares were sold for -1.0% lower than average price of previous purchases. This resulted in an overall loss of USD 111 The average price that the ETF previously sold HUM share for is USD 284.303 which is higher than the selling price of USD 270.48 on 2025-03-26. |
| HUM - Humana Inc | SELL | -41 @ USD 270.48 | USD -11,090 | The ETF sold 41 shares of HUM on 2025-03-26. The shares were previously bought for an average price of USD 273.181. The Humana Inc shares were sold for -1.0% lower than average price of previous purchases. This resulted in an overall loss of USD 111 The average price that the ETF previously sold HUM share for is USD 284.303 which is higher than the selling price of USD 270.48 on 2025-03-26. |
| RMD - ResMed Inc | SELL | -50 @ USD 221.88 | USD -11,094 | The ETF sold 50 shares of RMD on 2025-03-26. The shares were previously bought for an average price of USD 236.789. The ResMed Inc shares were sold for -6.3% lower than average price of previous purchases. This resulted in an overall loss of USD 745 The average price that the ETF previously sold RMD share for is USD 245.976 which is higher than the selling price of USD 221.88 on 2025-03-26. |
| CAH - Cardinal Health Inc | SELL | -84 @ USD 133.98 | USD -11,254 | The ETF sold 84 shares of CAH on 2025-03-26. The shares were previously bought for an average price of USD 125.949. The Cardinal Health Inc shares were sold for 6.4% higher than average price of previous purchases. This sale made a profit of USD 675 The average price that the ETF previously sold CAH share for is USD 121.141 so the ETF has sold 84 shares on 2025-03-26 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -95 @ USD 119.9 | USD -11,391 | The ETF sold 95 shares of A on 2025-03-26. The shares were previously bought for an average price of USD 134.477. The Agilent Technologies Inc shares were sold for -10.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,385 The average price that the ETF previously sold A share for is USD 135.907 which is higher than the selling price of USD 119.9 on 2025-03-26. |
| IDXX - IDEXX Laboratories Inc | SELL | -29 @ USD 417.71 | USD -12,114 | The ETF sold 29 shares of IDXX on 2025-03-26. The shares were previously bought for an average price of USD 440.978. The IDEXX Laboratories Inc shares were sold for -5.3% lower than average price of previous purchases. This resulted in an overall loss of USD 675 The average price that the ETF previously sold IDXX share for is USD 431.851 which is higher than the selling price of USD 417.71 on 2025-03-26. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -156 @ USD 81 | USD -12,636 | The ETF sold 156 shares of GEHC on 2025-03-26. The shares were previously bought for an average price of USD 87.386. The GE HealthCare Technologies Inc. shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 996 The average price that the ETF previously sold GEHC share for is USD 83.8667 which is higher than the selling price of USD 81 on 2025-03-26. |
| EW - Edwards Lifesciences Corp | SELL | -203 @ USD 71.09 | USD -14,431 | The ETF sold 203 shares of EW on 2025-03-26. The shares were previously bought for an average price of USD 70.9147. The Edwards Lifesciences Corp shares were sold for 0.2% higher than average price of previous purchases. This sale made a profit of USD 36 The average price that the ETF previously sold EW share for is USD 69.233 so the ETF has sold 203 shares on 2025-03-26 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -58 @ USD 271.39 | USD -15,741 | The ETF sold 58 shares of COR on 2025-03-26. The shares were previously bought for an average price of USD 247.098. The Cencora Inc. shares were sold for 9.8% higher than average price of previous purchases. This sale made a profit of USD 1,409 The average price that the ETF previously sold COR share for is USD 245.417 so the ETF has sold 58 shares on 2025-03-26 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -61 @ USD 337.29 | USD -20,575 | The ETF sold 61 shares of HCA on 2025-03-26. The shares were previously bought for an average price of USD 334.849. The HCA Holdings Inc shares were sold for 0.7% higher than average price of previous purchases. This sale made a profit of USD 149 The average price that the ETF previously sold HCA share for is USD 335.211 so the ETF has sold 61 shares on 2025-03-26 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -99 @ USD 228 | USD -22,572 | The ETF sold 99 shares of BDX on 2025-03-26. The shares were previously bought for an average price of USD 231.865. The Becton Dickinson and Company shares were sold for -1.7% lower than average price of previous purchases. This resulted in an overall loss of USD 383 The average price that the ETF previously sold BDX share for is USD 226.554 so the ETF has sold 99 shares on 2025-03-26 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -36 @ USD 640.14 | USD -23,045 | The ETF sold 36 shares of REGN on 2025-03-26. The shares were previously bought for an average price of USD 727.394. The Regeneron Pharmaceuticals Inc shares were sold for -12.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,141 The average price that the ETF previously sold REGN share for is USD 787.867 which is higher than the selling price of USD 640.14 on 2025-03-26. |
| ZTS - Zoetis Inc | SELL | -153 @ USD 162.82 | USD -24,911 | The ETF sold 153 shares of ZTS on 2025-03-26. The shares were previously bought for an average price of USD 169.232. The Zoetis Inc shares were sold for -3.8% lower than average price of previous purchases. This resulted in an overall loss of USD 981 The average price that the ETF previously sold ZTS share for is USD 176.898 which is higher than the selling price of USD 162.82 on 2025-03-26. |
| CVS - CVS Health Corp | SELL | -432 @ USD 67.2 | USD -29,030 | The ETF sold 432 shares of CVS on 2025-03-26. The shares were previously bought for an average price of USD 61.4263. The CVS Health Corp shares were sold for 9.4% higher than average price of previous purchases. This sale made a profit of USD 2,494 The average price that the ETF previously sold CVS share for is USD 56.9891 so the ETF has sold 432 shares on 2025-03-26 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -44 @ USD 663.02 | USD -29,173 | The ETF sold 44 shares of MCK on 2025-03-26. The shares were previously bought for an average price of USD 602.529. The McKesson Corporation shares were sold for 10.0% higher than average price of previous purchases. This sale made a profit of USD 2,662 The average price that the ETF previously sold MCK share for is USD 604.422 so the ETF has sold 44 shares on 2025-03-26 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -92 @ USD 321.23 | USD -29,553 | The ETF sold 92 shares of CI on 2025-03-26. The shares were previously bought for an average price of USD 311.344. The Cigna Corp shares were sold for 3.2% higher than average price of previous purchases. This sale made a profit of USD 910 The average price that the ETF previously sold CI share for is USD 322.369 which is higher than the selling price of USD 321.23 on 2025-03-26. |
| ELV - Elevance Health Inc | SELL | -80 @ USD 430.53 | USD -34,442 | The ETF sold 80 shares of ELV on 2025-03-26. The shares were previously bought for an average price of USD 406.299. The Elevance Health Inc shares were sold for 6.0% higher than average price of previous purchases. This sale made a profit of USD 1,938 The average price that the ETF previously sold ELV share for is USD 408.29 so the ETF has sold 80 shares on 2025-03-26 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -80 @ USD 430.53 | USD -34,442 | The ETF sold 80 shares of ELV on 2025-03-26. The shares were previously bought for an average price of USD 406.299. The Elevance Health Inc shares were sold for 6.0% higher than average price of previous purchases. This sale made a profit of USD 1,938 The average price that the ETF previously sold ELV share for is USD 408.29 so the ETF has sold 80 shares on 2025-03-26 at a higher price than the previous selling average. |
| MDT - Medtronic PLC | SELL | -440 @ USD 88.23 | USD -38,821 | The ETF sold 440 shares of MDT on 2025-03-26. The shares were previously bought for an average price of USD 89.2421. The Medtronic PLC shares were sold for -1.1% lower than average price of previous purchases. This resulted in an overall loss of USD 445 The average price that the ETF previously sold MDT share for is USD 86.7439 so the ETF has sold 440 shares on 2025-03-26 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -695 @ USD 59.21 | USD -41,151 | The ETF sold 695 shares of BMY on 2025-03-26. The shares were previously bought for an average price of USD 57.9147. The Bloomsbury Publishing Plc shares were sold for 2.2% higher than average price of previous purchases. This sale made a profit of USD 900 The average price that the ETF previously sold BMY share for is USD 57.0055 so the ETF has sold 695 shares on 2025-03-26 at a higher price than the previous selling average. |
| SYK - Stryker Corporation | SELL | -115 @ USD 367.77 | USD -42,294 | The ETF sold 115 shares of SYK on 2025-03-26. The shares were previously bought for an average price of USD 382.046. The Stryker Corporation shares were sold for -3.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,642 The average price that the ETF previously sold SYK share for is USD 380.756 which is higher than the selling price of USD 367.77 on 2025-03-26. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -88 @ USD 500.28 | USD -44,025 | The ETF sold 88 shares of VRTX on 2025-03-26. The shares were previously bought for an average price of USD 475.84. The Vertex Pharmaceuticals Inc shares were sold for 5.1% higher than average price of previous purchases. This sale made a profit of USD 2,151 The average price that the ETF previously sold VRTX share for is USD 480.758 so the ETF has sold 88 shares on 2025-03-26 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -219 @ USD 210.41 | USD -46,080 | The ETF sold 219 shares of DHR on 2025-03-26. The shares were previously bought for an average price of USD 222.539. The Danaher Corporation shares were sold for -5.5% lower than average price of previous purchases. This resulted in an overall loss of USD 2,656 The average price that the ETF previously sold DHR share for is USD 238.374 which is higher than the selling price of USD 210.41 on 2025-03-26. |
| DHR - Danaher Corporation | SELL | -219 @ USD 210.41 | USD -46,080 | The ETF sold 219 shares of DHR on 2025-03-26. The shares were previously bought for an average price of USD 222.539. The Danaher Corporation shares were sold for -5.5% lower than average price of previous purchases. This resulted in an overall loss of USD 2,656 The average price that the ETF previously sold DHR share for is USD 238.374 which is higher than the selling price of USD 210.41 on 2025-03-26. |
| GILD - Guild Esports Plc | SELL | -427 @ USD 109.27 | USD -46,658 | The ETF sold 427 shares of GILD on 2025-03-26. The shares were previously bought for an average price of USD 101.325. The Guild Esports Plc shares were sold for 7.8% higher than average price of previous purchases. This sale made a profit of USD 3,393 The average price that the ETF previously sold GILD share for is USD 93.2009 so the ETF has sold 427 shares on 2025-03-26 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -1,937 @ USD 25.21 | USD -48,832 | The ETF sold 1937 shares of PFE on 2025-03-26. The shares were previously bought for an average price of USD 26.2703. The Pfizer Inc shares were sold for -4.0% lower than average price of previous purchases. This resulted in an overall loss of USD 2,054 The average price that the ETF previously sold PFE share for is USD 26.1968 which is higher than the selling price of USD 25.21 on 2025-03-26. |
| BSX - Boston Scientific Corporation | SELL | -505 @ USD 102.34 | USD -51,682 | The ETF sold 505 shares of BSX on 2025-03-26. The shares were previously bought for an average price of USD 98.1547. The Boston Scientific Corporation shares were sold for 4.3% higher than average price of previous purchases. This sale made a profit of USD 2,114 The average price that the ETF previously sold BSX share for is USD 89.4077 so the ETF has sold 505 shares on 2025-03-26 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -505 @ USD 102.34 | USD -51,682 | The ETF sold 505 shares of BSX on 2025-03-26. The shares were previously bought for an average price of USD 98.1547. The MULSTRXSSXIMETFP shares were sold for 4.3% higher than average price of previous purchases. This sale made a profit of USD 2,114 The average price that the ETF previously sold BSX share for is USD 89.4077 so the ETF has sold 505 shares on 2025-03-26 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -184 @ USD 305.71 | USD -56,251 | The ETF sold 184 shares of AMGN on 2025-03-26. The shares were previously bought for an average price of USD 303.887. The Amgen Inc shares were sold for 0.6% higher than average price of previous purchases. This sale made a profit of USD 335 The average price that the ETF previously sold AMGN share for is USD 297.65 so the ETF has sold 184 shares on 2025-03-26 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -122 @ USD 509.03 | USD -62,102 | The ETF sold 122 shares of ISRG on 2025-03-26. The shares were previously bought for an average price of USD 553.046. The Intuitive Surgical Inc shares were sold for -8.0% lower than average price of previous purchases. This resulted in an overall loss of USD 5,370 The average price that the ETF previously sold ISRG share for is USD 536.769 which is higher than the selling price of USD 509.03 on 2025-03-26. |
| TMO - Time Out Group plc | SELL | -130 @ USD 513.67 | USD -66,777 | The ETF sold 130 shares of TMO on 2025-03-26. The shares were previously bought for an average price of USD 539.594. The Time Out Group plc shares were sold for -4.8% lower than average price of previous purchases. This resulted in an overall loss of USD 3,370 The average price that the ETF previously sold TMO share for is USD 534.735 which is higher than the selling price of USD 513.67 on 2025-03-26. |
| ABT - Abbott Laboratories | SELL | -591 @ USD 126.61 | USD -74,827 | The ETF sold 591 shares of ABT on 2025-03-26. The shares were previously bought for an average price of USD 125.52. The Abbott Laboratories shares were sold for 0.9% higher than average price of previous purchases. This sale made a profit of USD 644 The average price that the ETF previously sold ABT share for is USD 117.062 so the ETF has sold 591 shares on 2025-03-26 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -863 @ USD 88.11 | USD -76,039 | The ETF sold 863 shares of MRK on 2025-03-26. The shares were previously bought for an average price of USD 93.9805. The Marks Electrical Group PLC shares were sold for -6.2% lower than average price of previous purchases. This resulted in an overall loss of USD 5,066 The average price that the ETF previously sold MRK share for is USD 101.376 which is higher than the selling price of USD 88.11 on 2025-03-26. |
| MRK - Merck & Company Inc | SELL | -863 @ USD 88.11 | USD -76,039 | The ETF sold 863 shares of MRK on 2025-03-26. The shares were previously bought for an average price of USD 93.9805. The Merck & Company Inc shares were sold for -6.2% lower than average price of previous purchases. This resulted in an overall loss of USD 5,066 The average price that the ETF previously sold MRK share for is USD 101.376 which is higher than the selling price of USD 88.11 on 2025-03-26. |
| ABBV - AbbVie Inc | SELL | -602 @ USD 201.3 | USD -121,183 | The ETF sold 602 shares of ABBV on 2025-03-26. The shares were previously bought for an average price of USD 191.46. The AbbVie Inc shares were sold for 5.1% higher than average price of previous purchases. This sale made a profit of USD 5,924 The average price that the ETF previously sold ABBV share for is USD 185.862 so the ETF has sold 602 shares on 2025-03-26 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -819 @ USD 161.72 | USD -132,449 | The ETF sold 819 shares of JNJ on 2025-03-26. The shares were previously bought for an average price of USD 158.207. The Johnson & Johnson shares were sold for 2.2% higher than average price of previous purchases. This sale made a profit of USD 2,877 The average price that the ETF previously sold JNJ share for is USD 154.454 so the ETF has sold 819 shares on 2025-03-26 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -314 @ USD 518.2 | USD -162,715 | The ETF sold 314 shares of UNH on 2025-03-26. The shares were previously bought for an average price of USD 537.146. The UnitedHealth Group Incorporated shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 5,949 The average price that the ETF previously sold UNH share for is USD 587.007 which is higher than the selling price of USD 518.2 on 2025-03-26. |
| LLY - Eli Lilly and Company | SELL | -269 @ USD 826.76 | USD -222,398 | The ETF sold 269 shares of LLY on 2025-03-26. The shares were previously bought for an average price of USD 842.332. The Eli Lilly and Company shares were sold for -1.8% lower than average price of previous purchases. This resulted in an overall loss of USD 4,189 The average price that the ETF previously sold LLY share for is USD 803.877 so the ETF has sold 269 shares on 2025-03-26 at a higher price than the previous selling average. |